[Health in all policies in the Valencian Community: steps towards the health impact assessment].

Salud en todas las políticas en la Comunitat Valenciana: pasos hacia la evaluación del impacto en salud.
Determinantes sociales de la salud Equidad en salud Evaluación del impacto en salud Health equity Health impact assessment Políticas públicas Public policy Social determinants of health

Journal

Gaceta sanitaria
ISSN: 1578-1283
Titre abrégé: Gac Sanit
Pays: Spain
ID NLM: 8901623

Informations de publication

Date de publication:
Historique:
received: 04 09 2018
accepted: 05 09 2018
pubmed: 17 12 2018
medline: 4 4 2020
entrez: 17 12 2018
Statut: ppublish

Résumé

This paper describes the beginning of the implementation process of the health impact assessment in the Valencian Community (Spain), as an instrument to incorporate the framework of social determinants and health inequalities in the policies issued by the different departments of the Valencian government. The proposal involves: 1) political commitment, with legislative and strategic planning actions; 2) the creation of structures to allow intersectoral collaboration, with the establishment of the health impact assessment commission and the intersectoral technical committee; and 3) the design and validation of a tool for the simplified health impact assessment of non-health policies adapted to the Valencian Community. We highlight the importance of the participatory methodology used in the whole process and the potential of the health impact assessment for the development of public policies oriented to improve health and equity.

Identifiants

pubmed: 30553532
pii: S0213-9111(18)30233-4
doi: 10.1016/j.gaceta.2018.09.002
pii:
doi:

Types de publication

Journal Article

Langues

spa

Sous-ensembles de citation

IM

Pagination

593-597

Informations de copyright

Copyright © 2018 SESPAS. Publicado por Elsevier España, S.L.U. All rights reserved.

Auteurs

Rosa Mas-Pons (R)

Dirección General de Salud Pública, Conselleria de Sanitat Universal i Salut Pública, Valencia, España; Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), Valencia, España. Electronic address: mas_ros@gva.es.

Carmen Barona-Vilar (C)

Dirección General de Salud Pública, Conselleria de Sanitat Universal i Salut Pública, Valencia, España; Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), Valencia, España; CIBER de Epidemiología y Salud Pública (CIBERESP), España.

Guillem Ninyoles (G)

Dirección General de Salud Pública, Conselleria de Sanitat Universal i Salut Pública, Valencia, España.

Ana M García (AM)

Dirección General de Salud Pública, Conselleria de Sanitat Universal i Salut Pública, Valencia, España.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH